Analysis of Aurora B kinase in non-Hodgkin lymphoma

Takayuki Ikezoe(Fukushima Medical University), Akihito Yokoyama(Kōchi University)

Laboratory Investigation

October 12, 2009

10.1038/labinvest.2009.106

Cited by 39

Related Papers

Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation

|Theranostics|2021|156

A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia

|Molecular Cancer Therapeutics|2007|131

Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells

|Leukemia|2008|86

Downregulation of miR‐217 correlates with resistance of ph<sup>+</sup> leukemia cells to <scp>ABL</scp> tyrosine kinase inhibitors

|Cancer Science|2013|60

Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia

|International Journal of Cancer|2011|47